SCHEMBL2332155

SCHEMBL2332155

OCCN(CCO)CCOCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 3/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NAAA Q02083 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LYPLA1 O75608 1/20 0.40
LYPLA2 O95372 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
OPRK1 P41145 1/20 0.40
CTSB P07858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28428860 1.00 TSHR (0.56) TSHRKDM4EPOLBHTTALDH1A1
SCHEMBL12013320 0.96 TSHR (0.52) TSHRKDM4EPOLBHTTALDH1A1
SCHEMBL10622030 0.91 HTT (0.49) TSHRKDM4EPOLBHTTALDH1A1
SCHEMBL31036611 0.91 TSHR (0.46) TSHRKDM4EHTTLMNAHSD17B10
SCHEMBL12531323 0.90 DRD1 (0.46) TSHRKDM4EHTTALDH1A1LMNA
SCHEMBL28420914 0.83 CA1 (0.50) TSHRALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL31482290 0.83 TSHR (0.39) TSHRKDM4EPOLBHTTALDH1A1
SCHEMBL22319935 0.82 ALDH1A1 (0.50) TSHRKDM4EPOLBHTTALDH1A1
SCHEMBL30997661 0.81 TSHR (0.56) TSHRHTTNAAASMN1; SMN2LYPLA1
SCHEMBL7134224 0.81 TSHR (0.56) TSHRKDM4EPOLBNAAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110243892-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES JI SHISHAN 2011-10-06 US claimed
EP-1496076-B1 HYDROPHILIC POLYMER DERIVATE WITH Y TYPE BRANCH AND PREPARATION METHOD OF IT MEDICAL COMPOSITE COMPRISING ABOVE COMPOUND BEIJING JIANKAI TECHNOLOGY CO (CN) 2007-07-25 EP claimed
US-20050180946-A1 Hydrophilic polymer derivative with y type branch and preparation method of it medical cpmposite comprising above compund BEIJING JIANKAI TECHNOLOGY CO., LTD. (CN) 2005-08-18 US claimed
EP-1496076-A1 HYDROPHILIC POLYMER DERIVATE WITH Y TYPE BRANCH AND PREPARATION METHOD OF IT MEDICAL COMPOSITE COMPRISING ABOVE COMPOUND Beijing Jiankai Technology Co., Ltd. (CN) 2005-01-12 EP claimed
US-20110243892-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES JI SHISHAN 2011-10-06 US disclosed
US-20110243892-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES JI SHISHAN 2011-10-06 US disclosed
US-8003089-B2 such as triethanolamine with 2 hydroxyethyl groups derivatized with polyethylene glycol, and the amine group conjugated to drugs such as antitumor agent interferon BEIJING JIANKAI TECHNOLOGY CO., LTD. (CN) 2011-08-23 US disclosed
US-8003089-B2 such as triethanolamine with 2 hydroxyethyl groups derivatized with polyethylene glycol, and the amine group conjugated to drugs such as antitumor agent interferon BEIJING JIANKAI TECHNOLOGY CO., LTD. (CN) 2011-08-23 US disclosed
US-20100221213-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES JI SHISHAN 2010-09-02 US disclosed
US-20100221213-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES JI SHISHAN 2010-09-02 US disclosed
EP-1496076-B1 HYDROPHILIC POLYMER DERIVATE WITH Y TYPE BRANCH AND PREPARATION METHOD OF IT MEDICAL COMPOSITE COMPRISING ABOVE COMPOUND BEIJING JIANKAI TECHNOLOGY CO (CN) 2007-07-25 EP disclosed
EP-1496076-B1 HYDROPHILIC POLYMER DERIVATE WITH Y TYPE BRANCH AND PREPARATION METHOD OF IT MEDICAL COMPOSITE COMPRISING ABOVE COMPOUND BEIJING JIANKAI TECHNOLOGY CO (CN) 2007-07-25 EP disclosed
US-20050180946-A1 Hydrophilic polymer derivative with y type branch and preparation method of it medical cpmposite comprising above compund BEIJING JIANKAI TECHNOLOGY CO., LTD. (CN) 2005-08-18 US disclosed
EP-1496076-A1 HYDROPHILIC POLYMER DERIVATE WITH Y TYPE BRANCH AND PREPARATION METHOD OF IT MEDICAL COMPOSITE COMPRISING ABOVE COMPOUND Beijing Jiankai Technology Co., Ltd. (CN) 2005-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050180946-A1 Hydrophilic polymer derivative with y type branch and preparation method of it medical cpmposite comprising above compund SLC10A2, FLT3, PGF TSHR 1288/4885KDM4E 1446/4885POLB 1465/4885
US-20100221213-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES EGFR, NPY5R, NPY4R TSHR 1401/4885KDM4E 340/4885POLB 2847/4885
US-20110243892-A1 Y-SHAPE BRANCHED HYDROPHILIC POLYMER DERIVATIVES, THEIR PREPARATION METHODS, CONJUGATES OF THE DERIVATIVES AND DRUG MOLECULES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE CONJUGATES EGFR, NPY5R, NPY4R TSHR 1401/4885KDM4E 340/4885POLB 2847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.